# Metabolism of warfarin enantiomers in Japanese patients with heart disease having different CYP2C9 and CYP2C19 genotypes*

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/metabolism-of-warfarin-enantiomers-in-japanese-patients-with-heart-disease/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Harumi Takahashi,Toshitaka Kashima,Yuko Nomizo,Nagisa Muramoto,Teppei Shimizu,Kayoko Nasu,Takahiro Kubota,Sosuke Kimura,Hirotoshi Echizen |
| Citations | 184 |
| DOI | 10.1016/s0009-9236(98)90103-5 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine,Pharmacology, Toxicology and Pharmaceutics |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W1967783552 |
| PMID | 9630825 |
| Type | article |
| Year | 1998 |

## Paper authors

- [Hirotoshi Echizen](https://scholariq.org/researchers/hirotoshi-echizen/)

## Paper primary topic

- [Pharmacogenetics and Drug Metabolism](https://scholariq.org/topics/pharmacogenetics-and-drug-metabolism/)

## Paper topics

- [Pharmacogenetics and Drug Metabolism](https://scholariq.org/topics/pharmacogenetics-and-drug-metabolism/)
- [Eicosanoids and Hypertension Pharmacology](https://scholariq.org/topics/eicosanoids-and-hypertension-pharmacology/)
- [Antiplatelet Therapy and Cardiovascular Diseases](https://scholariq.org/topics/antiplatelet-therapy-and-cardiovascular-diseases/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.